Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TRO19622 for chemotherapy-induced peripheral neuropathy
2008-001218-26Phase 2Completed
- Sponsor
- Trophos
- Start
- May 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in chemotherapy-induced peripheral neuropathy (CIPN) and drug-induced peripheral neuropathy (DIPN) comparing TRO19622 330 mg QD with Placebo (2 arms). Primary endpoint: Responder rate in neuropathic pain/dysesthesia. Started May 2008; status: completed.
02
Drugs
olesoxime
03
Conditions
chemotherapy-induced peripheral neuropathy (CIPN)drug-induced peripheral neuropathy (DIPN)
Beyond the preview
Go deeper on 2008-001218-26.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-001218-26.